With regard to all federal funding provided to MySafe Society since January 2020: (a) what are the details of each contribution, grant and contract, including the (i) department or agency providing the funding, (ii) total value, (iii) start and end dates, (iv) purpose of the funding; (b) for each expenditure in (a), did the agreement require MySafe Society to report to the government on (i) participant health outcomes, (ii) overdose events, (iii) diversion of dispensed substances to unregistered individuals; (c) what reporting, if any, was received by the government under the requirements in (b); (d) was any audit or evaluation of the agreements in (a) conducted, and, if so, what were the findings; (e) what are the details of any federal funding specifically used for the acquisition, installation or operation of drug-dispensing machines, including the (i) number of machines funded, (ii) locations where machines were installed, (iii) total federal contribution toward the machines; and (f) at the time each funding agreement was signed, was the federal government aware that MySafe Society would be using federal funds to dispense opioids through machines, and, if so, (i) which department or official approved the funding with that knowledge, (ii) what controlled substances were known to be dispensed, (iii) what safeguards, if any, were required as a condition of funding?
Q-955 , 45th Parliament, 1st session May 26, 2025, to present
Question details
Asked by
Burton Bailey
(Red Deer)
Date asked
March 12, 2026
Answered
May 6, 2026
Response from
Department of Health
Topics
Response details
Responses details
Responses to written questions are provided by the relevant federal institutions. For accessibility issues or additional information, see the About page.
[]
{}